Accéder au contenu
Merck
  • Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Archives of oral biology (2014-06-16)
Ting Yang, Jing Zhang, Yukun Cao, Mian Zhang, Lei Jing, Kai Jiao, Shibin Yu, Meiqing Wang
RÉSUMÉ

Subchondral bone loss in mandibular condyles was reported to be induced by experimentally created unilateral anterior crossbite (UAC) which altered the occlusal load distribution and hereafter the temporomandibular joint (TMJ) remodelling process. However, the initial cellular responses are poorly understood. In the present study, changes in osteoblast and osteoclast activities in TMJ subchondral bone were investigated using the rats treated with UAC. Forty rats were randomly divided into UAC and control groups, and sampled at 2 weeks after the operation. Subchondral bone loss was evaluated by micro-CT. Osteoclast and osteoblast activities were analyzed by real-time PCR. The osteoblast differentiation of the locally isolated BMSCs from TMJ subchondral bone was assessed by Alizarin red staining. The migration of BMSCs was detected by transwell assays. Compared with the age-matched controls, TMJ subchondral bone loss was observed in the UAC-treated rats (p<0.05). The osteoblast activity evaluated by real-time PCR and osteoblast number revealed by immunohistochemical staining were reduced in the TMJ subchondral bone of UAC rats (p<0.05), and the capability of proliferation, migration and osteoblast differentiation were all decreased in the locally isolated BMSCs from the UAC group (p<0.05). The present data demonstrated an involvement of reduced BMSCs activity in the initiation of the mandibular subchondral bone loss at the early stage of installation of the aberrant prostheses.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dexaméthasone, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
3-Isobutyl-1-méthylxanthine, ≥99% (HPLC), powder
Sigma-Aldrich
L-acide ascorbique, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-acide ascorbique, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Iodure de propidium, ≥94.0% (HPLC)
Sigma-Aldrich
3-Isobutyl-1-méthylxanthine, ≥99%, BioUltra
Sigma-Aldrich
L-acide ascorbique, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Dexaméthasone, ≥98% (HPLC), powder
Sigma-Aldrich
L-acide ascorbique, reagent grade, crystalline
USP
Acide ascorbique, United States Pharmacopeia (USP) Reference Standard
Supelco
L-acide ascorbique, analytical standard
Sigma-Aldrich
L-acide ascorbique, reagent grade
Sigma-Aldrich
L-acide ascorbique, meets USP testing specifications
Sigma-Aldrich
Dexaméthasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-acide ascorbique, FCC, FG
Sigma-Aldrich
L-acide ascorbique, 99%
Sigma-Aldrich
L-acide ascorbique, BioUltra, ≥99.5% (RT)
USP
Dexaméthasone, United States Pharmacopeia (USP) Reference Standard
Supelco
L-acide ascorbique, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-acide ascorbique, ACS reagent, ≥99%
Sigma-Aldrich
Dexaméthasone, meets USP testing specifications
Sigma-Aldrich
Iodure de propidium solution
Sigma-Aldrich
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe, ≥97% (HPLC)
Supelco
Dexaméthasone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-acide ascorbique, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
Iodure de propidium, ≥94% (HPLC)
L-acide ascorbique, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-acide ascorbique, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L-acide ascorbique, tested according to Ph. Eur.
Supelco
L-acide ascorbique, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland